What is Eckert & Ziegler SE Price-to-Free-Cash-Flow?
As of today (2024-12-13), Eckert & Ziegler SE's share price is €45.78.
Eckert & Ziegler SE's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €1.98. Hence, Eckert & Ziegler SE's Price-to-Free-Cash-Flow Ratio for today is 23.18.
The historical rank and industry rank for Eckert & Ziegler SE's Price-to-Free-Cash-Flow or its related term are showing as below:
MIL:1EUZ'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 6.02 Med: 19.81 Max: 349.24
Current: 23.96
During the past 13 years, Eckert & Ziegler SE's highest Price-to-Free-Cash-Flow Ratio was 349.24. The lowest was 6.02. And the median was 19.81.
MIL:1EUZ's Price-to-Free-Cash-Flow is ranked better than 60.57% of 350
companies
in the Medical Devices & Instruments industry
Industry Median: 32.575
vs MIL:1EUZ: 23.96
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Eckert & Ziegler SE was 134.30% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -9.10% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was -12.60% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 9.70% per year.
During the past 13 years, Eckert & Ziegler SE's highest 3-Year average Free Cash Flow per Share Growth Rate was 100.00% per year. The lowest was -40.10% per year. And the median was 12.05% per year.
Eckert & Ziegler SE Price-to-Free-Cash-Flow Historical Data
The historical data trend for Eckert & Ziegler SE's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Eckert & Ziegler SE's Price-to-Free-Cash-Flow
For the Medical Devices subindustry, Eckert & Ziegler SE's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eckert & Ziegler SE's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Eckert & Ziegler SE's Price-to-Free-Cash-Flow falls into.
Eckert & Ziegler SE Price-to-Free-Cash-Flow Calculation
Eckert & Ziegler SE's Price-to-Free-Cash-Flow ratio for today is calculated as
Eckert & Ziegler SE's Share Price of today is €45.78. Eckert & Ziegler SE's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.98.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Eckert & Ziegler SE (MIL:1EUZ) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Eckert & Ziegler SE Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Eckert & Ziegler SE's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. It is predominantly engaged in the business of cancer therapy, industrial radiometry, and nuclear medical imaging. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MIL:1EUZ has been successfully added to your 